Investigation of neuroprotective activity of apolipoprotein E peptide mimetic Cog1410 in transgenic lines of drosophila melanogaster

   


1. Petersburg Institute of Nuclear Physics
2. Division of Neurology, Duke University Medical Center
3. Petersburg Institute of Nuclear Physics; Institute for Experimental Medicine, Russian Academy of Medical Sciences
Type: Clinical study
DOI: 10.18097/pbmc20146004515      UDK: 577.112.6      PubMed Id: 25249536
Year: 2014 vol: 60  issue:4  pages: 515-521
Abstract: The neuroprotective activity of apolipoprotein E (apoE) peptide mimetic Cog1410, containing amino acid sequence of the receptor-binding domain apoE, has been investigated in transgenic lines of Drosophila melanogaster expressing human APP and beta-secretase. Expression of two transgenes caused neuropathological processes attributed to Alzheimer's disease: neurodegeneration, cognitive abnormality and amyloid deposits formation in brain. It was shown that Cog 1410 reduces neurodegeneration in brain of transgenic flies and improves cognitive functions (odor recognition). These data suggest that Cog1410 is a potential neuroprotector that can be used in AD treatment.
Download PDF:
Reference: Latypova E.M., Timoshenko S.I., Kislik G.A., Vitek M.P., Schwarzman A.L., Sarantseva S.V., Investigation of neuroprotective activity of apolipoprotein E peptide mimetic Cog1410 in transgenic lines of drosophila melanogaster, Biomeditsinskaya khimiya, 2014, vol: 60(4), 515-521.
This paper is also available as the English translation:10.1134/S1990750814010107
Bibliography
 2016(Vol:62)
 2015(Vol:61)
 2014(Vol:60)
 2013(Vol:59)
 2012(Vol:58)
 2011(Vol:57)
 2010(Vol:56)
 2009(Vol:55)
 2008(Vol:54)
 2007(Vol:53)
 2006(Vol:52)
 2005(Vol:51)
 2004(Vol:50)
 2003(Vol:49)